Danaher Corp. | Cash Flow

Fiscal year is January-December. All values USD Millions.
2013
2014
2015
2016
2017
2018
Net Income before Extraordinaries
2,695
2,598
1,747
2,153
2,470
2,651
Depreciation, Depletion & Amortization
895
939
881
1,128
1,238
1,308
Other Funds
-
21
3
700
60
154
Funds from Operations
3,598
3,679
3,504
3,417
3,404
3,917
Changes in Working Capital
12
80
298
105
74
105
Net Operating Cash Flow
3,585
3,758
3,802
3,522
3,478
4,022
Capital Expenditures
552
598
513
590
620
Sale of Fixed Assets & Businesses
-
-
-
-
33
Purchase/Sale of Investments
959
254
44
265
138
Net Investing Cash Flow
553
3,444
14,951
5,243
908
Cash Dividends Paid - Total
52
228
354
400
378
Issuance/Reduction of Debt, Net
1,731
103
9,159
2,978
2,665
Net Financing Cash Flow
1,606
218
9,050
2,043
3,034
Net Change in Cash
1,437
110
2,215
173
333
Free Cash Flow
3,034
3,161
3,289
2,932
2,858
Deferred Taxes & Investment Tax Credit
255
177
184
384
427
195
Net Assets from Acquisitions
957
3,131
14,248
4,880
450
Other Sources
-
30
66
32
-
Change in Capital Stock
177
133
249
165
69
Exchange Rate Effect
10
206
116
149
131
Other Uses
2
-
213
70
9

About Danaher

View Profile
Address
2200 Pennsylvania Avenue NW
Washington District of Columbia 20037
United States
Employees -
Website http://www.danaher.com
Updated 07/08/2019
Danaher Corp. operates as a medical company, which designs, manufactures, and markets healthcare, environmental, and industrial equipment. It operates through the following segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions. The Life Sciences segment offers a range of research and clinical tools that scientists use to study cells and cell components in order to understand the causes of diseases; identify new therapies; and test new drugs and vaccines.